Renal Biomarkers for Treatment Effect of Ranibizumab for Diabetic Macular Edema

AIMS: To investigate the correlations between renal biomarkers and the treatment outcomes of ranibizumab for diabetic macular edema (DME). METHODS: This hospital-based study retrospectively enrolled 88 eyes from 67 patients who had received one-year intravitreal ranibizumab treatment for DME. Best-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Ivan Pochou, Huang, Wei-Lun, Yang, Chung-May, Yang, Chang-Hao, Ho, Tzyy-Chang, Hsieh, Yi-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450296/
https://www.ncbi.nlm.nih.gov/pubmed/32908935
http://dx.doi.org/10.1155/2020/7239570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450296/
https://www.ncbi.nlm.nih.gov/pubmed/32908935
http://dx.doi.org/10.1155/2020/7239570

Ejemplares similares